Target intelligence / Profile preview

Zinc transporter (ZnT and ZIP) (ZnT/ZIP)

Target
ZnT/ZIP
Molecular classification
Transporter, Solute carrier
01

Overview

Zinc transporters are a superfamily of integral membrane proteins essential for maintaining cellular zinc homeostasis, categorized into two primary families: the Solute Carrier 30 (SLC30 or ZnT) and Solute Carrier 39 (SLC39 or ZIP) families (Kambe et al., 2015, Physiological Reviews). The ZnT family functions to reduce cytoplasmic zinc concentrations by transporting zinc out of the cell or into intracellular organelles, whereas the ZIP family increases cytoplasmic zinc by facilitating its entry from the extracellular space or release from internal stores (Fukada & Kambe, 2011, Metallomics). These transporters are vital for the structural and catalytic function of over 300 enzymes and thousands of zinc-finger transcription factors, thereby influencing cell growth, immune response, and signal transduction (Bin et al., 2018, International Journal of Molecular Sciences). Dysregulation of specific transporters is linked to various pathologies, such as SLC30A8 in Type 2 diabetes and SLC39A4 in the severe deficiency disorder acrodermatitis enteropathica (Sladek et al., 2007, Nature; Kury et al., 2002, Nature Genetics). Therapeutic strategies targeting these transporters include the use of zinc ionophores like PBT2 to redistribute zinc in neurodegenerative diseases or the development of inhibitors to modulate zinc-dependent signaling in cancer (Adlard et al., 2008, Neuron).

Other names
Solute carrier family 30Solute carrier family 39ZnTZIPSLC30SLC39Zinc carrier
02

Mechanism of action

Modulation of cellular zinc levels through the regulation of zinc influx (facilitated by the ZIP/SLC39 family) and zinc efflux or organelle sequestration (facilitated by the ZnT/SLC30 family).

03

Biological functions

Zinc homeostasisIon transportSignal transductionCellular metabolismEnzyme regulationApoptosis regulation
04

Disease associations

Diabetes mellitusAcrodermatitis enteropathicaAlzheimer's diseaseCancerEhlers-Danlos syndromeInflammationHypozincemia
05

Safety considerations

Zinc-induced copper deficiencyGastrointestinal irritationOff-target transport of other divalent cations (e.g., manganese, cadmium)Systemic zinc toxicity
06

Interacting drugs

Zinc sulfate

5 more in the full profile.

07

Biomarkers

Serum zinc levelsSLC30A8 (ZnT8) autoantibodiesZIP4 expression levelsIntracellular labile zinc

Beyond the preview

Go deeper on Zinc transporter (ZnT and ZIP) (ZnT/ZIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc transporter (ZnT and ZIP) (ZnT/ZIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call